Skip to main content
An official website of the United States government
Email

Improving Resilience And Equity In Colorectal Cancer Screening: Lessons From Covid-19 And Beyond | November 2-4, 2020 | Virtual Meeting

Meeting Overview and Summary

This workshop was the second in the President’s Cancer Panel’s (the Panel) 2020–2021 series on cancer screening. The workshop brought together stakeholders from several sectors, including clinical care, healthcare systems, insurance companies, government agencies, research, and advocacy. Participants discussed barriers and opportunities related to colorectal cancer screening, including those relevant to the healthcare system disruptions caused by the coronavirus disease (COVID-19) pandemic.

Download the full meeting summary (PDF).

Agenda

Day 1: November 2, 2020

Day 1 Recording

Time Agenda Item
1:00 - 1:10 p.m.

Agenda Review and Administrative Statements

President's Cancer Panel introduction, administrative remarks, agenda review

1:10 - 2:00 p.m.

Introductions and Working Group Work to Date

Working Group and Stakeholder Panel introductions, planning process overview, and review of Working Group work to date

2:00 - 3:00 p.m.

Colorectal Cancer Screening Improvement Opportunities Session 1: Greater Promotion of FIT

Opportunities to improve screening, associated barriers, and possible solutions

  • Reflect on opportunities and barriers
  • Discuss and contribute ideas on ways to address the most significant barriers
3:00 - 3:15 p.m. Break
3:15 - 4:15 p.m.

Colorectal Cancer Screening Improvement Opportunities Session 2: Greater Access to Colonoscopy and Discussion of Options

Opportunities to improve screening, associated barriers, and possible solutions

4:15 - 4:35 p.m.

Working Group Review of Input and Final Comments

Review of the day's stakeholder input and reactions to day's work

4:35 - 5:00 p.m. Response to Public Questions and Comments

Day 2: November 4, 2020

Day 2 Recording

Time Agenda Item
1:00 - 1:15 p.m.

Agenda Review and Administrative Statements

Administrative remarks, facilitator introduces agenda and process, reflections from day 1

1:15 - 2:15 p.m.

Colorectal Cancer Screening Improvement Opportunities Session 3: Guidelines (Lower Age for Discussing CRC to Age 45)

Opportunities to improve screening, associated barriers, and possible solutions

2:15 - 3:15 p.m.

Colorectal Cancer Screening Improvement Opportunities Session 4: Risk Based Approach to Screening and Management

Opportunities to improve screening, associated barriers, and possible solutions

3:15 - 3:30 p.m. Break
3:30 - 4:30 p.m.

Colorectal Cancer Screening Improvement Opportunities Session 5: Improved Follow-Up, Management, and Treatment if Pathology is Found

Opportunities to improve screening, associated barriers, and possible solutions

4:30 - 4:40 p.m.

Working Group Review of Input and Final Comments

Brief review of input and panel discussion of next steps

4:40 - 5:00 p.m. Response to Public Questions and Comments

Participants

Name Title & Affiliations
Carolyn R. Aldigé

Founder and Chief Executive Officer Prevent Cancer Foundation® Alexandria, VA

Al B. Benson, III, MD, FACP, FASCO

Professor of Medicine Division of Hematology/Oncology Northwestern University Feinberg School of Medicine Chicago, IL

Durado Brooks, MD, MPH Deputy Chief Medical Officer Exact Sciences Madison, WI
Christian Cable, MD Designated Institutional Official Baylor Scott & White Medical Center Temple, TX
Gloria D. Coronado, PhD

Mitch Greenlick Endowed Distinguished Investigator Kaiser Permanente Northwest Center for Health Research Portland, OR

Anjee Davis, MPPA

President Fight Colorectal Cancer Springfield, MO

Samir Gupta, MD

Professor of Medicine, University of California San Diego Chief, Section of Gastroenterology Department of Veterans Affairs San Diego Healthcare System San Diego, CA

Heather Hampel, MS

Professor, Department of Internal Medicine Associate Director, Division of Human Genetics The Ohio State University Columbus, OH

Todd Hartley

Chief Executive Officer WireBuzz Scottsdale, AZ

Ernest T. Hawk, MD

Vice President for Cancer Prevention Division of Cancer Prevention and Population Sciences The University of Texas MD Anderson Cancer Center Houston, TX

Candace Henley, CPN

President Blue Hat Foundation Chicago, IL

James Hotz, MD, MACP

Clinical Services Director Albany Area Primary Health Care Albany, GA

Thomas F. Imperiale, MD

Professor of Medicine Department of Medicine Indiana University School of Medicine Indianapolis, IN

Rachel Issaka, MD, MAS

Assistant Professor Clinical Research Division of Gastroenterology and Hepatology Fred Hutchinson Cancer Research Center University of Washington Seattle, WA

Steven H. Itzkowitz, MD

Professor of Medicine and Oncological Sciences Director, Gastrointestinal Fellowship Program Mount Sinai Hospital Icahn School of Medicine New York, NY

Maureen R. Johnson, PhD

Executive Secretary, President's Cancer Panel Special Assistant, Office of the Director National Cancer Institute National Institutes of Health Bethesda, MD

Djenaba Joseph, MD, MPH

Medical Director Colorectal Cancer Control Program Centers for Disease Control and Prevention Atlanta, GA

David Lieberman, MD

Professor of Medicine Chief, Division of Gastroenterology and Hepatology Oregon Health and Science University Portland VA Medical Center Portland, OR

Jennifer Malin, MD, PhD

Senior Medical Director Oncology and Genetics UnitedHealthcare Minneapolis, MN

Elena Martinez, PhD

Sam M. Walton Endowed Chair for Cancer Research and Professor of Public Health Associate Director, Population Sciences, Disparities, and Community Engagement University of California San Diego Moores Cancer Center La Jolla, CA

Folasade May, MD, PhD

Assistant Professor of Medicine, University of California Los Angeles Director, Quality Improvement in Gastroenterology UCLA Health Culver City, CA

Rebecca A. Miksad, MD, MMS, MPH

Senior Medical Director Flatiron Health New York, NY

Edith P. Mitchell, MD, MACP, FCPP

Member, President's Cancer Panel Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology Director, Center to Eliminate Health Disparities Associate Director of Diversity Affairs Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia, PA

Stacy E. Potts, MD, MEd

Vice Chair of Education Family Medicine and Community Health University of Massachusetts Medical School Worcester, MA

Diana Redwood, PhD, MPH

Senior Epidemiologist Alaska Native Epidemiology Center Alaska Native Tribal Health Consortium Anchorage, AK

Michael Sapienza, MM

Chief Executive Officer Colorectal Cancer Alliance Washington, DC

Kevin B. Weiss, MD

Chief Officer, Sponsoring Institutions and Clinical Learning Environments Accreditation Council for Graduate Medical Education Professor of Medicine Northwestern University Feinberg School of Medicine Chicago, IL

Richard C. Wender, MD

Chair, Family Medicine and Community Health University of Pennsylvania Perelman School of Medicine Philadelphia, PA

John P. Williams, MD, FACS Chair, President's Cancer Panel Medical Director, Breast Cancer School for Patients Gainesville, VA
Keith L. Winfrey, MD

Chief Medical Officer New Orleans East Louisiana Community Health Center New Orleans, LA

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Improving Resilience And Equity In Colorectal Cancer Screening: Lessons From Covid-19 And Beyond | November 2-4, 2020 | Virtual Meeting was originally published by the National Cancer Institute.”

Email